July 24, 2019
June 12, 2019
The development of biosimilar versions of Lucentis and Eylea is of high interest in the ophthalmology market given the high cost of these agents, the large patient population suffering from retinal…
June 12, 2019
The development of biosimilar versions of Lucentis and Eylea is of high interest in the ophthalmology market given the high cost of these agents, the large patient population suffering from retinal…
May 29, 2019
March 19, 2019
December 27, 2018
November 14, 2018
November 8, 2018
October 26, 2018
September 23, 2018
August 22, 2018